Wallroth Donald E.
Chief Financial Officer at Molecular Insight Pharmaceuticals, Inc.
- Sold, on record
- $25k
- Dollars the filings state
- Form 4 sales
- 1
- Latest May 22, 2009
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Molecular Insight Pharmaceuticals, Inc.Chief Financial Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Molecular Insight Pharmaceuticals, Inc.UnusualMay 22, 2009 2009
Sold 6,500 shares at $3.78 ($25k)
Wallroth Donald E., Chief Financial Officer
Sold 32.5% of holdings ($76k position)13,500 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (1)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2009 | May 26, 2009 | Molecular Insight Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 6,500 | $25k | 32.5% | Unusual | SEC |